Deepak Dalvie - ringer Ingelheim Pharmaceuticals, Inc, University of Washington

基本信息

浏览量：44

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 130 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Oral Paltusotine, a Nonpeptide Selective Somatostatin Receptor 2 Agonist: Mass Balance, Absolute Bioavailability and Metabolism in Healthy Participants

Rosa Luo,Ajay Madan, Christine T Ferrara-Cook,Deepak Dalvie, Lance Goulet,R Scott Struthers, Alan S Krasner

British journal of clinical pharmacology (2025)

引用0浏览0WOS引用

Abstract ND02: Discovery of BMS-986365, a Ligand-Directed Androgen Receptor Degrader (AR LDD) with a Dual Mechanism-of-action and Best-in-class Potential, for the Treatment of Advanced Prostate Cancer

Shuichan Xu,Surendra Nayak,John D. Norris,Massimo Ammirante, Emyly Rychak,Suzanne E. Wardell,Toshiya Tsuji, Ken Liu, Joseph Meiring,Joseph R. Piccotti,Deepak Dalvie,Debbie Liao,Raju Kandimalla, Nadia Guerrero,Lisa Sapinoso,Jennifer G. Baker,Yeeun Bae, Joshua Baughman, Brandon Toyama, Fontanillo,Stephen Norris,Evan J. Horn,Veronique Plantevin-Krenitsky,Deborah Mortensen,Brian Cathers, Marie Hong Nguyen, Joshua D. Hensen,Lawrence G. Hamann,Donald P. McDonnell,Rama Krishna Narla,Mark Rolfe

CANCER RESEARCH（2024）

引用2浏览0引用

Utilizing Mechanistic Organic Chemistry Training to Study Drug Metabolism in Preclinical Drug Discovery/development

Deepak Dalvie,Amit S. Kalgutkar

Medicinal Chemistry Research（2023）

引用0浏览0引用

SAT182 Effects of an Orally Bioavailable Nonpeptide Parathyroid Hormone Receptor Type 1 (PTH1R) Antagonist in Rodent Models of Primary Hyperparathyroidism (PHPT)

Agnes S Antwan,Elizabeth Rico-Bautista, Joe Pontillo,Shimiao Wang,Michael Johns, Bastian Ramms,Melissa A Fowler,Julie B Nguyen, Anel A Castellanos Gonzalez,Beth Fleck, Kelsey Retting,Deepak Dalvie,Stephen F Betz,Stacy Markison

Journal of the Endocrine Societyno. Supplement_1 (2023)

引用0浏览0引用

FRI538 Discovery and Characterization of Orally Bioavailable Nonpeptide Thyroid Stimulating Hormone Receptor (TSHR) Antagonists for the Treatment of Graves’ Disease

Melissa A Fowler, Collin Regan,Jian Zhao,Eulalia Coutinho,Beth Fleck, Anel A Castellanos, Eric Muller,Michael Johns, Yang Tang,Emmanuel Sturchler,Mi Chen, Kelsey Retting,Deepak Dalvie,Stephen F Betz,Stacy Markison

Journal of the Endocrine Societyno. Supplement_1 (2023)

引用0浏览0引用

Disposition and Metabolism of Ozanimod–surmounting the Unanticipated Challenge Late in Development

Deepak Dalvie,Sekhar Surapaneni

Overcoming Obstacles in Drug Discovery and Developmentpp.239-247, (2023)

引用0浏览0引用

Future of Biotransformation Science in the Pharmaceutical Industry

Valerie M Kramlinger,Deepak Dalvie,Carley J S Heck,Amit S Kalgutkar, James O'Neill,Dian Su,Aaron M Teitelbaum,Rheem A Totah

Drug Metabolism and Dispositionno. 3 (2021): 258-267

引用10浏览0WOS引用

Investigation into MAO B–Mediated Formation of CC112273, a Major Circulating Metabolite of Ozanimod, in Humans and Preclinical Species: Stereospecific Oxidative Deamination of (S)-Enantiomer of Indaneamine (RP101075) by MAO B

April Bai,Veerabahu Shanmugasundaram,Julie Selkirk,Sekhar Surapaneni,Deepak Dalvie

Drug Metabolism and Dispositionno. 8 (2021): 601-609

引用9浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn